These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19801534)

  • 1. Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age.
    Naderali EK; Ratcliffe SH; Dale MC
    Am J Alzheimers Dis Other Demen; 2009 Dec-2010 Jan; 24(6):445-9. PubMed ID: 19801534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and cognitive aging.
    Dahl AK; Hassing LB
    Epidemiol Rev; 2013; 35():22-32. PubMed ID: 23258415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and diabetes.
    Dash SK
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):155-65. PubMed ID: 23489242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in cognitive impairment and Alzheimer's disease.
    Li R; Singh M
    Front Neuroendocrinol; 2014 Aug; 35(3):385-403. PubMed ID: 24434111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
    Arvanitakis Z; Capuano AW; Leurgans SE; Bennett DA; Schneider JA
    Lancet Neurol; 2016 Aug; 15(9):934-943. PubMed ID: 27312738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.
    Daulatzai MA
    Neurotox Res; 2013 Oct; 24(3):407-59. PubMed ID: 23820984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between body mass index and incidental mild cognitive impairment, Alzheimer's disease and vascular dementia in elderly.
    Doruk H; Naharci MI; Bozoglu E; Isik AT; Kilic S
    J Nutr Health Aging; 2010 Dec; 14(10):834-8. PubMed ID: 21125201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
    Luchsinger JA
    Eur J Pharmacol; 2008 May; 585(1):119-29. PubMed ID: 18384771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.
    Musicco M; Palmer K; Salamone G; Lupo F; Perri R; Mosti S; Spalletta G; di Iulio F; Pettenati C; Cravello L; Caltagirone C
    J Neurol; 2009 Aug; 256(8):1288-95. PubMed ID: 19353221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.
    Iadecola C; Yaffe K; Biller J; Bratzke LC; Faraci FM; Gorelick PB; Gulati M; Kamel H; Knopman DS; Launer LJ; Saczynski JS; Seshadri S; Zeki Al Hazzouri A;
    Hypertension; 2016 Dec; 68(6):e67-e94. PubMed ID: 27977393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for vascular dementia and Alzheimer disease.
    Gorelick PB
    Stroke; 2004 Nov; 35(11 Suppl 1):2620-2. PubMed ID: 15375299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular risk factors: imaging and neuropathologic correlates.
    Knopman DS; Roberts R
    J Alzheimers Dis; 2010; 20(3):699-709. PubMed ID: 20182020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired insulin secretion increases the risk of Alzheimer disease.
    Rönnemaa E; Zethelius B; Sundelöf J; Sundström J; Degerman-Gunnarsson M; Berne C; Lannfelt L; Kilander L
    Neurology; 2008 Sep; 71(14):1065-71. PubMed ID: 18401020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.
    de Oliveira FF; de Almeida SS; Chen ES; Smith MC; Naffah-Mazzacoratti MDG; Bertolucci PHF
    J Alzheimers Dis; 2018; 65(4):1283-1299. PubMed ID: 30149448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the risk for conversion from mild cognitive impairment to Alzheimer's disease in an elderly Arab community.
    Inzelberg R; Massarwa M; Schechtman E; Strugatsky R; Farrer LA; Friedland RP
    J Alzheimers Dis; 2015; 45(3):865-71. PubMed ID: 25624416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and cognitive dysfunction.
    Ma L; Wang J; Li Y
    Clin Chim Acta; 2015 Apr; 444():18-23. PubMed ID: 25661087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.